1.Ethics Investigation and Analysis on Clinical Trials of Traditional Chinese Medicine in Ischemic Stroke Treatment
Yawei DU ; Jinzhou TIAN ; Hongfang LIU ; Jianwei SHANG
World Science and Technology-Modernization of Traditional Chinese Medicine 2014;(9):1989-1991
This article was based on the investigation of ethical research in traditional Chinese medicine (TCM) clini-cal trials among 240 ischemic stroke patients and 105 experts specialized in this field. Analysis was given on the re-search results. This article was intended to regulate the ethical review of ischemic stroke, and to protect the rights and interests of the subjects better.
2.Ethical Investigations and Considerations of Clinical Trials of TCM in Diabetic Nephropathy Management
Zhen WANG ; Jianwei SHANG ; Jinzhou TIAN ; Hongfang LIU
World Science and Technology-Modernization of Traditional Chinese Medicine 2013;(4):739-742
With the high incidence of diabetic nephropathy, the clinical trials of traditional Chinese medicine (TCM) in diabetic nephropathy area play an important role in the development of this subject. Therefore, follow-ing the principles of medical ethics, issues of fully understanding professional requirements of ethics review for clinical research of diabetic nephropathy and the protection of patients' rights are questions which should be solved. This article was based on the investigations on ethical needs of experts and patients in diabetic nephropathy area of TCM clinical trials . Discussions and considerations were made on results . A the more per-fect and regulated medical informed consent formwork for diabetic nephropathy of TCM clinical trials was made based on these consultations .
3.Problems and Countermeasures in the Ethical Review of Scientific Research Projects
Jianwei SHANG ; Jinzhou TIAN ; Xuechun TANG ; Jiuli ZHAO ; Yixin FAN ; Hongfang LIU
Chinese Medical Ethics 2017;30(3):336-338
Through analyzing the problems of time,selection mode,research plan,and tracking review in the ethical review of scientific research projects,this paper put forward the corresponding countermeasures:standardized application procedures,diverse selection mode,standardized research plan,and strict tracking review.It aimed to improve the quality of ethical review of scientific research projects and improve the ethical review system.
4.The effect of Qibaipingfei capsule on right ventricular hypertrophy index(RVHI)of rats with phlegm and blood stasis of COPD
Chuanbo WANG ; Zegeng LI ; Bo PENG ; Jiabing TONG ; Cheng YANG ; Sichun ZHANG ; Hongfang SHANG
International Journal of Traditional Chinese Medicine 2010;32(1):5-6
Objectlve To explore the effect of Qibai Pingfei capsule on the right ventricular hypertrophy index (RVHI)of rats with phlegm and blood stasis of COPD.Methods 60 rats were randomly divided into 6 groups,a control group,a model group,a Ligustrazine group,a Nifedipine group,a high dose Qibai Pingfei capsule group and a low dose Qibai Pingfei capsule group.Composite factors method was adopted to establish phlegm and blood stasis COPD rat model.At the same time of modeling.Qibai Pingfei capsule,Ligustrazine,Nifedipine were also given to these rats.Observed the changes of RVHI in each group.Results RVHI did not show statistic difierence between high dose of the Qibai Pingfei capsule group and the control group(P>0.05).and between the Nifedipine group and the model group(P>0.05).RVHI manifested significant diffbrencc between the Ligustrazine group and the low dose Qibai Pingfei capsule group(P<0.01),and between the Ligustrazine group and the control group(P<0.01).Conclusion High dose Qibai Pingfei capsule can effectively prevent the right ventricular hypertrophy of model rats with the phlegm and blood stasis of COPD.Ligustrazine has certain effects but not as good as high dose Qibai Pingfei capsule.Nifedipine can not prevent the right ventricular hypertrophy of model rats.
5.Discussion on Ethical Censorship of New Medical Technology
Jianwei SHANG ; Yixin FAN ; Jiuli ZHAO ; Xuechun TANG ; Yongtao ZHANG ; Hongfang LIU
World Science and Technology-Modernization of Traditional Chinese Medicine 2017;19(8):1267-1271
Since the Beijing health and family planning commission promulgated the new medical technology management system,we have accepted and reviewed 14 key medical technologies in Beijing,such as resection of the skull base tumor (intracranial tumor outside communication),resection of intracranial important functional areas and large vascular malformation,renal vascular reconstruction technique,the technique of artificial joint replacement,coronary interventional diagnosis and treatment technology,etc.Through the existing laws and regulations requirements from medical new technology,the ethical review way,submit materials requirements and ethical review focus is analyzed,and combining with the experiences of our hospital in the medical technical review,aims to explore suitable for medical technology ethical review specification.
6.Practice of applying multimedia technology in doctor-patient communication before diagnosis and treatment
Jiawei GU ; Qiang HE ; Jun ZHANG ; Bin ZHENG ; Liangming NIE ; Hongfang ZHANG ; Zhiqiang WU ; Jian SHEN ; Jinwen QI ; Lingcui FANG ; Liang ZHENG ; Minhui SHEN ; Feng TIAN ; Jie SHANG ; Yang GAO ; Chaoyang HONG
Chinese Journal of Hospital Administration 2021;37(2):127-129
The existing doctor-patient communication pattern often falls prey to insufficient informed consent and even medical disputes. In the patient centered perspective, Zhejiang Provincial People′s Hospital explored a new communication mode centering on patients. Based on diagnosis-related groups catalogues and high-frequency surgeries catalogues of the departments, multimedia technology was called into play to produce dubbed PPTs and videos that were easy to understand, standardized and homogeneous, which were embedded into medical records system. Following observation of the PPT or video, patients could directly sign an informed consent on the computer. This practice not only deepens patient′s understanding and achieves homogeneous level of the communication, but also elevates doctor′s work efficiency, contributing to building a harmonious doctor-patient relationship.
7.Innovative practice of " two hearts and four wings" in the construction of safe hospital
Jiawei GU ; Jun ZHANG ; Bin ZHENG ; Liangming NIE ; Jian SHEN ; Hongfang ZHANG ; Zhiqiang WU ; Lingcui FANG ; Liang ZHENG ; Minhui SHEN ; Feng TIAN ; Jie SHANG ; Yang GAO ; Qiang HE
Chinese Journal of Hospital Administration 2021;37(6):514-517
The construction of safe hospital is the foundation of high-quality development of the hospital, and innovation provides power for the construction of safe hospital from the perspective of high-quality development. Taking Zhejiang Provincial People′s Hospital as an example, the authors introduced the innovation construction path of safe hospital in detail, and put forward the construction strategy of safe hospital with " two hearts" (patient-centered, employee-centered)and " four wings" (multimedia doctor-patient communication, Wulin aunt medical studio, integrated operation safety inspection, third-party medical liability insurance). Through the combination of basic safety management and innovative practice, the hospital vigorously promoted the culture of " two hearts" , and established an efficient collaborative information management system, so as to form replicable and promotable practical experience and promote the development of safe hospital.